Skip to main content
Premium Trial:

Request an Annual Quote

Jake Orville, Steven Paul

Premium
NextGen announced the appointment of Jake Orville as vice president of global sales. He will be responsible for the commercialization of NextGen’s products in North America, Europe, and the Far East. He replaces Geoff Alms who is now leading NextGen’s North American business development.
 
NextGen, based in Cambridge, UK, purchased Proteomic Research Services on Nov. 3, adding to its portfolio of protein synthesis services [See PM 11-09/06].
 
Orville was previously at Third Wave Technologies as VP of sales and business development.
 

 
Sigma-Aldrich’s board this week elected Steven Paul as a director. Paul is executive vice president for science and technology and president of the Lilly Research Laboratories of Eli Lilly. Prior to that, he was scientific director of the National Institute of Mental Health.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.